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Ochrobactrum anthropi is a Gram-negative, motile, non- 
fermentative, oxidase- and urease-positive, aerobic 
bacillus, formerly classified as Achrornobacter species 
or CDC group Vd, that belongs to the new genus 
Ochrobactrurn [l]. The organism is widely distributed in 
soil, environmental and water sources, including anti- 
septic solutions and dialysis fluid, and it has been 
recognized as part of the normal human flora of the 
large intestine. 0. anthropi has been rarely described as 
a human pathogen. Data concerning 0. anthropi infec- 
tions are scarce and come mainly from case reports. The 
majority of the infections were community acquired, 
and several reports have emphasized how the clinical 
syndrome caused by 0. anthropi infection was closely 
linked to the underlying condition of the host. We 
report what we believe is the first case of 0. anthropi 
non-catheter-related bacteremia in a previously healthy 
man. 
A 47-year-old man was admitted to our hospital 
complaining of a 10-day hstory offever and dry cough. 
On admission, his temperature was 39OC, the blood 
pressure was 150/95 mmHg and the pulse was 9Wmin. 
Blood was drawn for cultures, and thereafter the patient 
was given intravenous imipenem (2 g/day). He was a 
truck driver, and had no prior hospitdzation and no 
underlying disease. He was well until 10 days prior to 
admission, when he experienced fever to a maximum 
of 39S°C, chills, astenia, cough and dysuria. On  
physical examination, he showed hepatomegaly and 
diminished breath sounds in both lungs. A chest X-ray 
showed probable bilateral interstitial infdtrates. Arterial 
blood gases revealed pH 7.442, PCO;? 36.5 mmHg and 
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P O 2  72.8 mmHg. Laboratory findings included a white 
blood cell count of 47 OOO/L, with 63% neutrophils and 
27% lymphocytes, an erythrocyte sedimentation rate 
(ESR) of 41 mm/h, and a C-reactive protein level of 
9 mg/dL. Cultures of blood drawn on days 1, 2 and 
3 in hospital were all positive for 0. anthropi (API 20 
NE, bioMkrieux, Marcy l'Etoile, France), susceptible 
to amikacin, chloramphenicol, gentamicin, co- 
trimoxazole, amoxycillin, carbenicillin, ciprofloxacin 
and tobramycin, and resistant to all cephalosporins, 
imipenem and tetracycline. Despite the administration 
of a 5-day course of imipenem, fever persisted. The 
patient subsequently completed a 14-day course of 
intravenous ciprofloxacin, 400 mg/day, and became 
afebrile within 48 h; no fever and further symptoms 
have been noted, and repeated blood cultures were 
negative. 
In the past, 0. anthropi strains were included in 
the genus Achvomobacter. Holmes et al reviewed the 
confusing history and taxonomy of these organisms in 
1988, suggesting that they formed a single taxon that 
could be subdivided into three biotypes (biotypes A, B, 
and C). For these strains, these authors proposed a new 
genus and new species, 0. anthropi [l]. 
0. anthropi strains are rod-shaped, Gram-negative, 
non-pigmented, and motile by means of peritrichous 
flagella that are small in number and are laterally 
attached. All strains produce acid in ammonium salt 
medium under aerobic conditions from several carbo- 
hydrates, including glucose, arabinose, ethanol, fructose, 
rhamnose, and xylose, but not from lactose. They 
reduce both nitrate and nitrite [l], and may produce 
copious amount of slime within 24-48 h on carbo- 
hydrate-containing medium [2]. The cells are catalase- 
positive and oxidase-positive, and grow at 37"C, at 
room temperature (1 8-22OC), and on P-hydroxy- 
butyrate. Growth on MacConkey medium occurs easily, 
with a large, sticky cell mass on the surface. This 
bacterium is also able to grow on atrazine (khloro-4- 
ethylamino-6-isopropyl-amine-s-triazine) by utilizing 
it as the only source of nitrogen [3]. 
0. anthropi strains have been isolated from a variety 
of clinical specimens, particularly from blood, respira- 
tory tract, urogenital tract, and urine, and less frequently 
from wound, stool, throat, ear, vagina, and pus; 
however, the clinical significance of these organisms 
remained largely unknown [l]. Since the first descrip- 
tion of human infection with Achromobacter anthropi in 
a elderly woman with a pancreatic abscess in 1980 [4], 
this organism has been recognized as a potential human 
pathogen in only a few reports. Achromobacter anthropi 
has been described as a rare cause of systemic invasive 
disease, and there have been a small number of reports 
of clinically significant infection, including cases of 
catheter-related bacteremia [2,5-131 and urinary tract 
infection [6], soft-tissue abscess [14], puncture wound 
osteochondritis [15], and meningitis [16]. 
Recently, Cieslak et a1 [17] have described three 
cases of pyogenic infections caused by 0. anthropi 
(cholangitis, pulmonary abscess, and wound infection), 
thereby expanding the known pathogenic potential of 
this organism, and subsequently, Earhart et a1 [18] have 
reported a case of infection of retained pacemaker leads. 
A case of 0. anthropi endophthalmitis after uncom- 
plicated cataract surgery in a 66-year-old patient 
in good general health [19], and a case of bilateral 
endogenous endophthalmitis in a patient who had 
undergone central venous access for hyperalimentation 
and home intravenous therapy, have also been docu- 
mented [20]. 
0. anthropi was reported as the cause of an outbreak 
of nosocomial bacteremia in five organ transplant 
patients who had received a contaminated rabbit 
antithymocyte globulin, a thermolabile injectable drug 
that is susceptible to microbial contamination because, 
although produced aseptically, it is not heat sterilized 
[ 121. Extensive epidemiologic investigations established 
an intrinsic contamination of the globulin during the 
manufacturing process as the source of this outbreak 
[21]. 
Chang et al have documented a cluster of noso- 
comial meningitis cases transmitted by contaminated 
human pericardial tissue graft in three pediatric 
neurosurgical patients [16]. A preliminary investigation 
suggested the probable contamination of the pericardial 
grafts with 0. anthropi during processing or freezing 
In the case reported here, our patient was a healthy 
man with no underlying condition. Primary bacteremia 
has not previously been described in an immuno- 
logically normal host, although it is noteworthy that 0. 
anthropi is an emerging microorganism with docu- 
mented ability to cause bacteremia, mainly in chronically 
debilitated individuals. Severe immunosuppression and 
association with an indwelling medical device, in- 
cluding a central venous catheter (CVC) or a peritoneal 
dialysis catheter, have been described as the prominent 
factors associated with most cases of 0. anthropi 
bacteremia reported previously in the literature. 
A review of the English language literature revealed 
only 25 other cases of bloodstream infections caused by 
0. anthropi [2,5-14,211. Of the 25 cases studied, 18 
patients were female and seven male. Their ages ranged 
from 2 to 74 years. Two cases were identified in infants: 
the first case was a catheter-related bacteremia in a 3- 
year-old child with retinoblastoma [7], and the second 
case was a catheter-related bacteremia in a 2-year-old 
child with leukemia [9]. Among the 25 documented 
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cases, all but two of the patients were immuno- 
compromised or had underlying conditions: five 
patients were renal transplant recipients (one patient 
had received simultaneous kidney and pancreas grafts), 
four patients had leukemia, two patients had Crohn’s 
disease and short bowel, one patient had acute 
lymphatic leukemia and post-chemotherapy neutro- 
penia, and one other patient had Hodgkin’s disease 
and had received an autologous bone marrow 
transplant. 
Other underlying diseases included gastric ulcer, 
post-thoracic surgery, post-cardiac surgery, pancreatitis, 
peritonitis, rend failure, respiratory failure, and a 
variety of neoplastic diseases (including one case each 
of astrocytoma, retinoblastoma, rhabdomyosarcoma, 
and thymoma) . 
Although infections with 0. anthropi usually occur 
in patients with debilitating illnesses, these infechons 
have also been described in previously healthy patients. 
Gill et al [13] have described a case of intravenous line 
infection in a normal host, and Brivet et al [lo] have 
reported the first case of necrotizing fasciitis associated 
with 0. anthropi bacteremia in a non-immuno- 
compromised elderly woman. All but two patients 
survived; however, in the two patients who died, death 
was unrelated to 0. anthropi infection [8]. Bloodstream 
infections were successfully treated with intravenous 
antibiotics in eight cases [2,5-111, while in seven other 
cases catheter-related infection was managed success- 
fully with a combination of intravenous administration 
of antibiotics and removal of the catheter [8,9]. 
Removal of catheters without systemic antimicrobial 
therapy seemed to be associated with a favorable 
outcome in four cases [12]. 
Although 0. anthropi appears to be an organism of 
limited virulence, antimicrobial treatment of infections 
with this agent may be difficult, considering the 
variable susceptibility patterns. 
Most isolates of 0. anthropi reported in the 
literature are widely resistant to chloramphenicol and 
p-lactams, particularly cephalosporins, and penicillins 
[22]. Co-trimoxazole, quinolones, and aminoglyco- 
sides, particularly amikacin and gentamicin, appear to 
be most active agents. 
Herein, we report what we believe is the first case 
in which 0. anthropi was isolated &om the blood of a 
patient with spontaneous bacteremia. This patient did 
not have an intravenous device or any other type of 
foreign body, and there was no evidence of other 
predisposing conditions. In conclusion, awareness of 
the potential role of 0. anthropi in causing bloodstream 
infections, especially in seriously ill patients, has 
important clinical implications, given the serious 
morbidity associated with disseminated 0. anthropi 
infections and the resistance of this organism to a 
variety of antibiotics. 
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CASEREPORT 
A 29-year-old patient with AIDS was admitted with a 
3-week history of headache and a 1-week history of 
nausea. The patient was taking stavudine, dapsone and 
pyrimethamine for prophylaxis, ganciclovir for cyto- 
megalovirus (CMV) retinitis, and cortisone for adrenal 
failure. The clinical examination revealed nuchal 
rigidity and a temperature of 39°C. Apart from this, 
neurologic status was normal. There were no other 
clinical pathologic findings except for the known 
Kaposi's sarcoma lesions, and the patient had no 
pulmonary complaints, cough or sputum. The central 
nervous system (CNS) CT scan, performed im- 
mediately, was normal. A lumbar puncture showed clear 
cerebrospinal fluid (CSF) with 30 mm H20 opening 
pressure and 1.08 g/L proteins. Cytology revealed 19 
leukocytes/mL (polymorphonuclear 50%, lymphocytes 
47%, monocytes 21%, basophils 1% and eosinophils 
1%). There were no organisms on direct examination 
and the bacterial and fungal cultures were sterile. 
Cryptococcal antigen was negative in CSF and in blood. 
Serology for toxoplasmosis was negative. The patient 
was treated with ceftriaxone. Four days later, the patient 
developed a left motor hemisyndrome with anisocoria. 
A second CT scan showed a right pediculothalamic 
hypodensity. The CNS MRI showed meningeal axial 
and cranial enhancement after gadolinium injection 
in T1-weighted images of the interpeduncular opto- 
chiasmatic cisterns. T2-weighted axial images also 
showed hyperintensity of the medulla oblongata, the 
right peduncle and the right tectum, without contrast 
enhancement. The radiologic diagnosis was of basal 
cistern meningitis with bulbar-peduncular encephalitis. 
There was also a thickened left maxillary and right 
sphenoid sinus wall without fluid. Chest radiographs 
and the abdominal CT scan were normal. 
Another lumbar puncture showed clear CSF, 
1.58 g/L proteins; 2 erythrocytes/mL and 83 leuko- 
cytes/mL (83% polymorphonuclear, 4% lymphocytes, 
13% monocytes). Again, there were no organisms on 
Gram-stain direct examination. Polymerase chain 
reaction performed in the CSF for JC virus, CMV, 
Epstein-Barr virus and mycobacteria were all negative. 
Fungal cultures were also negative after 3 months for 
both CSF samples. Apart from one blood culture which 
was positive for Mycobacteriurn aviurn, all other blood 
cultures were negative. Serology in CSF showed posi- 
tive VDRL, but FTA and TPHA were both negative, 
and blood VDRL, FTA and TPHA were all negative. 
Two days later, the patient died in a comatose state. 
Autopsy was performed 26 h after death. At extraction 
of the brain, a purulent exudate was noted in the 
subarachnoid space around the pons, the chiasma and 
diaphragma sellae. In addition to purulent basilar 
meningitis, macroscopic analysis revealed thrombosis of 
